NFKB1 and type 2 diabetes mellitus: For example, metformin is a drug that is commonly used for the treatment of type 2 diabetes and can have anti-senescence effects by modulating key intracellular pathways related to SASP (e.g., NFκB and p53) and reducing circulating SASP53–55.